Search Results - S. A. Bely

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin

Get full text

Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely

Get full text

Prognostic value of troponin I after coronary artery bypass grafting (AMIRI-CABG study) by N. S. Bunenkov, V. V. Komok, S. A. Bely, A. V. Sokolov, V. I. Lukashenko, A. S. Nemkov, G. G. Khubulava

Get full text

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS by T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely

Get full text

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS by T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely

Get full text

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma by T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely

Get full text

CORRIGENDUM: “EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY” by T. Yu. Demidova, M. Ya. Izmailova, S. E. Ushakova, K. Ya. Zaslavskaya, A. A. Odegova, V. V. Popova, M. E. Nevretdinova, P. A. Bely

Get full text

EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY by T. Yu. Demidova, M. Ya. Izmailova, S. E. Ushakova, K. Ya. Zaslavskaya, A. A. Odegova, V. V. Popova, M. E. Nevretdinova, P. A. Bely

Get full text

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS by T. N. Komarov, P. A. Karpova, O. A. Archakova, D. S. Shchelgacheva, P. K. Karnakova, N. S. Bagaeva, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin

Get full text

CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY by D. N. Zemskov, L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, P. A. Bely, E. V. Semenova, M. V. Shirmankina, K. N. Koryanova

Get full text

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial by T. N. Komarov, K. K. Karnakova, N. S. Bagaeva, O. A. Archakova, M. O. Popova, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin

Get full text

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, I. E. Shohin

Get full text

Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity by A. S. Ametov, P. A. Bely, K. Y. Zaslavskaya, E. A. Rogozhina, V. S. Shcherbakova, Y. G. Kazaishvili, A. V. Taganov, T. G. Bodrova, E. S. Mishchenko, K. N. Koryanova, L. I. Shcherbakova

Get full text

Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, S. M. Noskov

Get full text

Analysis of cytokine response characteristics and immunopathogenetic effects of double-stranded sodium salt RNA-based drug for postexposure prophylaxis against novel coronavirus in... by O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, Yu. A. Kostina, N. A. Pyataev, N. M. Selezneva, A. V. Klimova, I. Yu. Chegodaeva, K. N. Koryanova, A. V. Taganov, P. A. Bely

Get full text

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD by O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, Yu. A. Kostina, E. V. Negodnova, S. V. Mashnina, D. D. Bessheinov, M. S. Iskandyarova, V. V. Eremeev, N. M. Chumakov

Get full text

MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION by L. A. Balykova, N. M. Selezneva, E. I. Gorshenina, O. I. Shepeleva, N. V. Kirichenko, E. N. Simakina, K. B. Kolontarev, D. Yu. Pushkar, D. N. Zemskov, K. Ya. Zaslavskaya, S. M. Noskov, A. V. Taganov, P. A. Bely

Get full text

The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals by A. A. Andreev-Andrievsky, M. A. Mashkin, M. Vannous, O. V. Fadeeva, Yu. G. Kazaishvili, D. V. Kurkin, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, E. A. Rogozhina, K. N. Koryanova, E. S. Mishchenko, T. G. Bodrova, V. S. Shcherbakova

Get full text

Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA... by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, K. A. Zakharov, V. V. Popova, T. I. Chudinovskikh, S. V. Teplykh, I. V. Balaban, R. S. Kozlov, N. V. Kirichenko, E. N. Simakina, K. N. Koryanova, D. Yu. Pushkar

Get full text

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, P. A. Bely, V. F. Pavelkina, N. A. Pyataev, A. Yu. Ivanova, G. V. Rodoman, N. E. Kostina, V. B. Filimonov, E. N. Simakina, D. A. Bystritsky, A. S. Agafyina, K. N. Koryanova, D. Yu. Pushkar

Get full text